Abbvie Inc Earnings

Abbvie Inc’s revenue jumped 5.6% since last year same period to $15102Mn in the Q4 2024. On a quarterly growth basis, Abbvie Inc has generated 4.44% jump in its revenue since last 3-months.

Abbvie Inc’s net profit fell -102.68% since last year same period to $-22Mn in the Q4 2024. On a quarterly growth basis, Abbvie Inc has generated -101.41% fall in its net profits since last 3-months.

Abbvie Inc’s net profit margin fell -102.53% since last year same period to -0.15% in the Q4 2024. On a quarterly growth basis, Abbvie Inc has generated -101.35% fall in its net profit margins since last 3-months.

Abbvie Inc’s price-to-earnings ratio after this Q4 2024 earnings stands at 72.38.

Abbvie Inc’s earning per share (EPS) estimates for the current quarter stand at 2.26 - a -22.67% fall from last quarter’s estimates.

Abbvie Inc’s earning per share (EPS) estimates for the current year stand at 2.26.

Abbvie Inc’s earning per share (EPS) fell -22.58% since last year same period to 2.16 in the Q4 2024. This indicates that the Abbvie Inc has generated -22.58% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Abbvie Inc’s return on assets (ROA) stands at 0.08.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Abbvie Inc’s return on equity (ROE) stands at 0.62.

Abbvie Inc declared 1.55 dividend per share during the earnings announcement for Q4 2024.